Cargando…

Sodium benzoate and rifaximin are able to restore blood-brain barrier integrity in he cirrhotic rats

Detalles Bibliográficos
Autores principales:	Thabut, D, Mouri, S, El Mourabit, H, Morichon, R, Wandum, D, Lasnier, E, Housset, C, Weiss, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798026/ http://dx.doi.org/10.1186/2197-425X-3-S1-A691

Ejemplares similares

Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
por: Tamai, Yasuyuki, et al.
Publicado: (2021)

Blood-brain barrier dysfunction assessed by protein S-100 beta levels in cirrhotic patients in ICU
por: Weiss, N, et al.
Publicado: (2015)

Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients
por: Chang, Ji Young, et al.
Publicado: (2017)

Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study
por: Lv, Xin-Yue, et al.
Publicado: (2020)

Reduction in Gastrointestinal Cancers in Cirrhotic Patients Receiving Rifaximin vs Lactulose Only Therapy for Hepatic Encephalopathy
por: Patel, Ankoor H, et al.
Publicado: (2023)

Uncovering Competitive and Restorative Effects of Macro- and Micronutrients on Sodium Benzoate Biodegradation
por: Zaveri, Purvi, et al.
Publicado: (2021)

Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy
por: Parisse, Simona, et al.
Publicado: (2023)

Variceal bleeding in cirrhotic patients
por: Mallet, Maxime, et al.
Publicado: (2017)

Benzoate of Sodium in Uremia
Publicado: (1888)

Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE
por: Flatt, Emmanuelle, et al.
Publicado: (2021)

Benzoate of Sodium in Throat Affections
Publicado: (1888)

Cirrhotic patients in icu with gastro-intestinal bleeding managed according to recent guidelines display altered brain hemoglobin oxygen’s saturation assessed by near infrared spectroscopy
por: Thabut, D, et al.
Publicado: (2015)

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
por: Pose, Elisa, et al.
Publicado: (2021)

Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
por: Fiorillo, Alessandra, et al.
Publicado: (2023)

Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
por: Kaji, Kosuke, et al.
Publicado: (2020)

Rifaximin enhances the L-carnitine-mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut-liver-muscle axis
por: Murata, Koji, et al.
Publicado: (2022)

Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

A Patient with MSUD: Acute Management with Sodium Phenylacetate/Sodium Benzoate and Sodium Phenylbutyrate
por: Köse, Melis, et al.
Publicado: (2017)

MRCK-Alpha and Its Effector Myosin II Regulatory Light Chain Bind ABCB4 and Regulate Its Membrane Expression
por: Bruneau, Alix, et al.
Publicado: (2022)

Microfibrillar Polysaccharide-Derived Biochars as Sodium Benzoate Adsorbents
por: Liu, Dagang, et al.
Publicado: (2017)

Rifaximin has the potential to prevent complications of cirrhosis
por: Flamm, Steven L., et al.
Publicado: (2018)

Rifaximin Prevents T-Lymphocytes and Macrophages Infiltration in Cerebellum and Restores Motor Incoordination in Rats with Mild Liver Damage
por: Balzano, Tiziano, et al.
Publicado: (2021)

Rifaximin Therapy of Irritable Bowel Syndrome
por: Koo, Hoonmo L., et al.
Publicado: (2012)

Rifaximin, Microbiota Biology, and Hepatic Encephalopathy
por: Peleman, Cedric, et al.
Publicado: (2016)

Rifaximin for Pertuzumab-Related GI Toxicities
por: Soyano, Aixa E., et al.
Publicado: (2017)

Efficacy of orally administered sodium benzoate and sodium phenylbutyrate in dogs with congenital portosystemic shunts
por: van Straten, Giora, et al.
Publicado: (2019)

Culture Model of Rat Portal Myofibroblasts
por: El Mourabit, Haquima, et al.
Publicado: (2016)

Role of Angiogenesis in the Pathogenesis of NAFLD
por: Lei, Lin, et al.
Publicado: (2021)

Rifaximin for maintenance therapy in antibiotic-dependent pouchitis
por: Shen, Bo, et al.
Publicado: (2008)

The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea
por: Koo, Hoonmo L, et al.
Publicado: (2009)

Rifaximin as Treatment for Hepatic Encephalopathy: Some Considerations
por: Ridola, Lorenzo, et al.
Publicado: (2013)

Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
por: Rezigh, Alec B., et al.
Publicado: (2018)

Diverticular Disease and Rifaximin: An Evidence-Based Review
por: Piccin, Anna, et al.
Publicado: (2023)

Stereological studies of the effects of sodium benzoate or ascorbic acid on rats’ cerebellum
por: Noorafshan, Ali, et al.
Publicado: (2014)

Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy
por: Kimer, Nina, et al.
Publicado: (2014)

Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans
por: Finlin, Brian S, et al.
Publicado: (2019)

Lactulose/rifaximin: Lack of drug effect: case report
Publicado: (2021)

Probing gut‐brain links in Alzheimer's disease with rifaximin
por: Suhocki, Paul V., et al.
Publicado: (2022)

Cost-Effectiveness of Rifaximin Treatment in Patients with Hepatic Encephalopathy
por: Jesudian, Arun B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jp3sgcqj950ef9ekc47l0ofn90